Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
10.93
-1.57 (-12.56%)
Mar 31, 2025, 1:29 PM EDT - Market open
Oruka Therapeutics Employees
Oruka Therapeutics had 28 employees as of December 31, 2024.
Employees
28
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,533,909
Market Cap
409.22M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ORKA News
- 24 days ago - Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting - GlobeNewsWire
- 24 days ago - Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Oruka Therapeutics to Present at Multiple March Investor Conferences - GlobeNewsWire
- 3 months ago - Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody - GlobeNewsWire
- 3 months ago - Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) - GlobeNewsWire
- 4 months ago - Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Oruka Therapeutics to Present at Multiple November Investor Conferences - GlobeNewsWire
- 6 months ago - Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress - GlobeNewsWire